Jump to Content Jump to Main Navigation

Volume 9 (2011): Issue Suppl_3 (Feb 2011): NCCN Oncology Pharmacy & Policy

in Journal of the National Comprehensive Cancer Network

Online ISSN:: 1540-1413

Print ISSN:: 1540-1405

Issue Contents

New NCCN Program Recognizes Organizations Supporting Coverage for Clinical Trials and Appropriate Off-Label Drug Usage

Pages: vii–ix
NCCN Trends

Pages: x
Take Your Medicine

By: Harold J. Burstein

Pages: S-1
A Quick REMS Update and a Clinical Focus

By: Edward C. Li

Pages: S-2–S-3
Informing Patients: Translating the NCCN Guidelines

By: Joan S. McClure

Pages: S-4–S-5
Biosimilars: Approval and Acceptance?

By: Jessica K. DeMartino

Pages: S-6–S-9
Where Your Data Is Going and Where It's Been

By: Jane M. Quigley

Pages: S-10–S-12
New Options for the Management of Castration-Resistant Prostate Cancer: A Case Perspective

By: Dawn Goetz

Pages: S-13–S-24
Pharmacotherapy for Chronic Myelogenous Leukemia: A Case-Based Approach

By: Stephen Harnicar

Pages: S-25–S-35
Safe and Successful Implementation of CPOE for Chemotherapy at a Children's Cancer Center

By: James M. Hoffman, Donald K. Baker, Scott C. Howard, Joseph H. Laver and Jerry L. Shenep

Pages: S-36–S-50

Save
Email
Share
Share
Share

Top

Journal of the National Comprehensive Cancer Network

Print ISSN:: 1540-1405

Online ISSN:: 1540-1413

Publisher:: Harborside Press, LLC

Cover Journal of the National Comprehensive Cancer Network